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Clinical Presentation and Diagnosis of 
Gastrointestinal Infections by Yersinia 
enterocolitica in 261 Dutch Patients
V IRG IN IA  M. M. STOLK-ENGELAAR and JACOM INA A.A. HOOGKAM P-KORSTANJE
From the Department oj Medical Microbiology, University Hospital Nijmegen, The Netherlands
A surveillance of the clinical manifestations, course and outcome of 261 patients with gastrointestinal infection by Yersinia 
enterocolitica between 1982 and 1991 was carried out. Acute uncomplicated enteritis was diagnosed in 169 patients, 
complicated enteritis in 37, appendicular syndrome in 33, ileitis in 8 and colitis in 14. Children (age < 1 6  years, « = 1 0 5 )  
presented most often with mild enteritis, young adults (age 16-25  years, // =  47) with enteritis or appendicular syndrome, 
adults (age >  25 years, / / =  109) liad significant risk for developing serious enteritis, ileitis and colitis. Complications included 
reactive arthritis, septicaemia, lymphadenitis, disturbed liver functions and erythema nodosum. Four patients died of 
generalized peritonitis. Diagnosis was established by positive culture in 207 patients. Another 54 patients were diagnosed by 
having at least two other positive tests: serum agglutinins, specific IgA and IgG antibodies to Yersinia outer membrane 
proteins (Yops) or antigen detection in biopsies. Culture alone was sufficient to diagnose uncomplicated enteritis, antiYops 
serology appeared to be very useful in diagnosing patients with other manifestations of yersiniosis. The majority of the 
infections were caused by serotypes 0 3  and 0 9  while unusual serotypes were associated with advancing age and colitis.
V. M. M. Stolk-Engelaar, Department o f  Medical Microbiology, University Hospital Nijmegen ^ P.O. Box 9101, NL-6500 
11B Nijmegen, The Netherlands
INTRODUCTION
Yersinia enterocolitica is a Gram-negative pathogen, asso­
ciated with a wide spectrum of enteric and systemic mani­
festations (1). Diagnosis is not easy because the disease has 
diverse clinical presentations and stool cultures require 
specific laboratory methods, most of which are not per­
formed routinely. Furthermore, stool cultures and serology 
by demonstration of circulating agglutinins are often nega­
tive in the more complicated forms (2, 3), and both may 
contribute to underestimation of the disease, In 1982 we 
began a study on Yersinia infections. At first all patients 
with enteritis were cultured for Y. enterocolitica and their 
physicians were asked to record all symptoms in cases with 
positive culture. They were also instructed to be alert for 
conditions commonly associated with Y. enterocolitica in­
fections. When no material was available for culture the 
agglutination test was performed. In 1986 we introduced 
determination of serum IgA and IgG antibodies against 
Yersinia outer membrane proteins (Yops) (4) and antigen 
detection in biopsies (5). The Yersinia agglutination test is
performed by the pathologist unaware of the results of 
culture or serology when biopsy specimens were available.
This study reports incidence and clinical manifestations 
of gastrointestinal infections by Y. enterocolitica during a 
9-year study period.
MATERIALS AND METHODS
Culture
Fecal samples were inoculated onto Yersinia selective agar (Oxoid 
CM653, PCH-Diagnostica, Haarlem, The Netherlands), deoxy- 
cholate citrate agar (Oxoid CM35, PCH-Diagnostica) and into 
Rappaport broth. Plates were incubated at 22°C for 48 h; broth 
was incubated at 22°C for 72 h and then subcultured on the same 
plates. Colonies suspected to be Yersinia were isolated and iden­
tified (9). Other materials (pus, blood) were routinely cultured for 
aerobic and anaerobic bacteria and in particular for Yersinia on 
selective agar and in Rappaport broth, incubated at 22°C for 72 h. 
Pus was also stored for cold enrichment in phosphate buffer (pH 
7.0) at 4°C for 3 weeks. Serotyping was performed as described 
earlier (5).
Fecal samples were also cultured for Salmonella, Shigella and 
Campylobacter species by standard microbiologic methods.
based on whole bacterial cells as antigens leading to cross- Serology 
reactivity with antibodies directed against some Brucella 
spp. and Enterobactedaceae. Yersinia virulence plasmids 
encoding for Yops have not yet been found in other 
Enterobacteriaceae, which makes this a more specific test 
than the agglutination test (6). IgA antibodies appear after 
about 10 days postinfection, followed by specific IgG anti­
bodies. In an acute infection IgA reactivity decreases 
rapidly after 3-6  months, whereas a decrease of IgG reac­
tivity is markedly retarded. In chronic infection persistent 
IgA and IgG reactivity is seen (7, 8). Antigen detection was
Agglutinins. Serum samples were titrated against unheated suspen­
sions (OD, MacFarland standard 5) of Y. enterocolitica serotype 
03, 05.27, 06.30, 07.8, 08 and 09 and Yersinia pseudotuberculo­
sis serotypes I-VI grown at 22°C for 48 h, with a standard 
agglutination test (2, 5). A titre of antibody >1:160 was consid­
ered significant. Positive, acute phase sera from patients with 
positive cultures and agglutinins-negative sera were used as con­
trols in each test run.
IgA and IgG antibodies against Yops. Specific IgA and IgG anti­
bodies against purified plasmid-encoded virulence-associated Yops 
of Y. enterocolitica serotype 08 (strain WA-314; Dr C. Pai,
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Table I. Demographic data o f  261 patients with enteric form s o f  yersiniosis
Disease No.
Age range (years)
0 - 5 6-10 11-15 16-25 26-40 > 40
Sex
M/F
Hospitalized
patients
Enteritis 169 60 10 12 22 32 33 84/85 33
Enteritis 4- complications 37 5 1 1 9 12 9 15/22 13
Appendicular syndrome 33 I 5 9 10 5 3 13/20 33
Ileitis 8 — — 1 1 4 2 2/6 8
Colitis 14 — — — 5 4 5 10/4 14
Montreal, Canada) in sera were demonstrated by immimoblotling 
techniques (4).
Antigens (molec wt: 25 kDa =  Yop E, 36 k D a = Y o p  D, 
38 kDa =  V-antigen, 46 kDa =  Yop H and 58 IcDa =  Yop M) were 
blotted onto a nitrocellulose filler (Sigma Chemical Co, St. Louis, 
MO, USA). Sera were diluted 1:100 in PBS-Tween (150 mM 
NaCl, 20 mM N a2H P 0 4 (pH 7,0) and 0.5% Tween-20) and incu­
bated with the antigen-coated nitrocellulose strips overnight at 
22°C. The IgG and IgA anLibody-antigen complexes formed were 
visualized according to the methods of Blake et al. (10). Control 
strips were reacted with human acute sera (culture-positive Y, 
enterocolitica infection) containing antibodies to the Yops and 
human negative sera in each test run. Positive reaction (IgG and 
IgA) in immunoblotting with at least two identical Yops was 
judged significant.
Antigen detection in biopsies
Biopsy specimens (enteric preparations) from patients were investi­
gated with serotype-specific (03, 05 , 08 , 09) and monospecific 
(Yad A and Yop H) rabbit antisera for the presence of Y. 
enterocolitica bacilli by indirect immunofluorescence (5). Positive 
controls consisted of tonsillar tissue contaminated with each of the
same serotypes of Y. enterocolitica.
Yersinia pseudotuberculosis; Salmonella typhimurium; Shigella 
sonnei; Campylobacter jejuni and mixtures of aerobic and anaero­
bic fecal (lora were used as negative controls. Rabbit antisera, in 
dilutions of 1:120-1:900, were added, followed by addition of 
FITC-conjugated horse anti se rum to rabbit IgG. The preparations 
with Y. enterocolitica showed a clear, sharp fluorescence of the cell 
wall. The reaction was serotype specific at dilutions >1:240; al 
lower dilutions slight cross-reactions were seen between the various 
serotypes. All negative controls gave no reaction.
Patients
Patients were identified from specimens sent to the Public Health 
Laboratory in Friesland (The Netherlands). This laboratory serves 
a province of 700,000 inhabitants with 8 general hospitals (2,100 
beds) and 260 general physicians. The study period was from 1 
July 1982 to 1 January 1991. Because specificity of the agglutina­
tion test is low and there is little information on specificity of the 
immunoblotting only patients who were culture-positive or had at 
least two of the other tests (agglutination» immunoblotting, antigen 
detection) positive, when culture-negative were included. Yersinia 
enterocolitica infection was diagnosed in 473 patients. A physician 
was asked to observe each patient with a proven Yersinia infection 
for at least 2 months to obtain information on specific symptoms 
[diarrhea (with or without blood), fever, nausea, vomiting, abdom­
inal pain, weight loss or other], complications (lymphadenitis, 
arthritis, erythema nodosum or other)» clinical course, duration of 
disease, family history, use o f  antibiotics, effect of treatment and 
outcome, underlying disease, drug abuse. A standard form to
record all data was used. Complete record forms were obtained 
from 403 patients. The patients with gastrointestinal disease (n = 
261) arc presented in this study. The other patients (// — 142) had 
complicated yersiniosis such as arthritis and erythema nodosum 
without gastrointestinal symptoms and will be reported separately.
The patients were arbitrarily classified into 4 groups: (1) enteritis 
with or without complications: patients starting with mild diarrhea 
and abdominal pain; (2) appendicular syndrome: those with acute 
abdominal pain in the right lower quadrant; (3) ileitis: patients 
with inflammation of the ileum confirmed by endoscopy; and (4) 
colitis: patients with inflammation of the colon confirmed by 
endoscopy.
Statistical analysis
The x2 test was used to assess the significance of differences 
between groups; in the case of small numbers the Fisher’s exact test 
was used, p  values are two-tailed.
RESULTS
Incidence
Yersinia enterocolitica was found in 2.4% of the fecal 
samples, Salmonella in 7.8%, Campylobacter in 4.6% and 
Shigella in 0.2%. Mixed infections were diagnosed in 0.3% 
(S. typhimurium and Y. enterocolitica) and 0.1% (C. jejuni 
and Y. enterocolitica), respectively. The patients with the 
mixed infections were excluded from the study. Yersinia 
infections showed no seasonal peak.
Clinical manifestations
Correlation between clinical manifestations, age, sex and 
hospitalization is presented in Table 1. Two patients had an 
underlying disease (rectal carcinoma and non-Hodgkin’s 
lymphoma, respectively). None of the patients was known 
to have abused alcoholic or used iron supplements.
Enteritis. Enteritis was diagnosed in 206 patients. Uncom­
plicated enteritis (169 patients) was relatively common in 
children with the highest incidence under the age of 2 years. 
A mild non bloody diarrhea was the most common symp­
tom. The duration before diagnosis was 1 week or longer if 
the diarrhea was relapsing; 34 patients had had periods of 
diarrhea for 2-3 months, whereas 6 had a prolonged 
course of up to 1 year afterwards. An acute onset was 
mentioned by 22%. Abdominal pain occurred more often in 
adults (>18 years, 64%) than in children (41%), vomiting 
more often in children (26%) than in adults (>18 years,
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Table II. Percentage o f  positive diagnostic methods related to clinical disease. The number o f  patients, positive I total tested is in parentheses
Disease
Method 
Culture 
Agglutinins 
Imnrmnoblot 
Antigen detection
Percentage of positive test
Enteritis
99 (162/164) 
48 (11/23)
88 (14/16) 
ND
uncompl (n ~  169) compì (// -  37)
Appendicular 
syndrome (// =  33) Ileitis (n = 8)
66 (21/32) 
42 ( 11/26) 
92 (22/24) 
94 (15/16)
80 (16/20) 
32 (7/22) 
100 (21/21) 
100 (18/18)
13 (1/8) 
38 (3/8) 
100 (8/8) 
100 (7/7)
Colitis (ti — 14)
50 (7/14) 
31 (4/13) 
80 (8/10) 
91 (10/11)
12%). Fever (31%) and weight loss (19%) were seen equally 
in all age groups. A total of 26 children and 7 adults needed 
hospitalization.
Yersinia-associated complications were observed in 37 
patients. They included septicaemia (/■/ = 3), generalized 
lymphadenitis (n = 5), localized lymphadenitis (mesenterial 
and inguinal, 72 — 4), arthritis (n — 15), erythema nodosum 
(n =  8) and disturbed liver functions (n =  7). Four patients 
had more than one complication. The patients with compli­
cations presented more often with fever (52%) than those 
with uncomplicated enteritis (31%). Antimicrobial treat­
ment was given to 38% of the patients with uncomplicated 
enteritis and to 75% with complicated enteritis. Various 
antimicrobial agents, including trimethoprim/sulfamethoxa- 
zol and ciprofloxacin, were used. Overall cure rate after 2 
months was 93% for uncomplicated yersiniosis and 71% for 
complicated forms; 17 (of 206) patients still complainedof 
relapsing diarrhea up to 1 year afterwards.
Appendicular syndrome. Presented as ‘acute abdomen’, oc­
curring in 33 patients, predominantly in young adults. 
Fever was observed in 36% and 30% had diarrhea. 15 
' patients had a history of chronic abdominal pain with 
weight loss (up to 15 kg in 6 months). 20 patients under­
went laparotomy; mesenteric lymphadenitis with terminal 
ileitis with a normal appendix was found in 50% and a 
slightly inflamed appendix in the others. Four patients had 
extensive intra-abdominal lymphadenitis with pseudotu- 
morous forms, 1 patient also had cholecystitis due to Y. 
enterocolitica. One of the patients developed generalized 
peritonitis and died. Cure without complications was 
achieved in 25 patients, 8 patients complained of abdomi­
nal pain after surgery during the follow-up for 1-12 
months.
Ileitis. Observed in 8 patients, 1 child (15 years) and 7 
adults. They suffered from chronic relapsing, sometimes 
bloody diarrhea with abdominal pain, fever and weight 
loss. The duration of symptoms at the time of diagnosis 
varied from 6 weeks to 3 years. At endoscopy the intestinal 
wall appeared diffusely swollen and erythematous with
signs of chronic inflammation. Three patients underwent 
ileocecal resection. At operation, extensive intra-abdominal 
lymphadenitis was found in 2 patients; 1 patient also had 
generalized peritonitis. The ileal resections showed inflam­
mation of submucosa and muscular areas with lymphocytic 
infiltrates, necrosis and sometimes granulomas. No giant 
cells or fistulae were observed. Yersinia-associated compli­
cations were reactive arthritis (n — 2) and erythema nodo­
sum (n = 2), Four patients were treated with antimicrobial 
agents (cotrimoxazole or doxycycline), 3 of them were 
cured and 1 relapsed. The other 4 patients became asymp­
tomatic without therapy.
Colitis. Severe enterocolitis was observed in 14 adults, 10 of 
them suffering from an acute generalized form; 4 had had 
a relapsing form of a more localized proctitis for 2 years. 
Patients with the acute form were very ill with high fever, 
bloody liquid stools and dehydration. On endoscopy, diffuse 
ulceration and inflammation of ileum and colon with perfo­
ration were observed; 5 patients had toxic megacolon. Three 
patients died despite antimicrobial treatment (cefopera- 
zone + gentamicin + metronidazole, doxycyclin, cefuroxim) 
and surgery. The other 7 patients with the acute form were 
cured with antimicrobial treatment (cotrimoxazole or 
ciprofloxacin or doxycyclin) and surgery. One of the 4 
patients with the more localized relapsing form still had 
symptoms during the follow-up despite antimicrobial treat­
ment (ciprofloxacin).
Yersinia-associated complications were; arthritis (n = 6) 
and erythema nodosum (/? = 1). Three patients showed 
disturbed liverfunctions.
Microbiology
Table II gives the results of diagnostic methods related to 
clinical presentation. Virtually all patients with uncompli­
cated enteritis from whom feces was cultured were culture- 
positive (99%), as were 80% of the patients with an 
appendicular syndrome and less than 50% of the patients
with ileitis and colitis.
The strains belonged to serotype 03 (97 strains), 09 (49 
strains), 08 (20 strains), 05.27 (13 strains), 07.8 (12
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strains), 06.3 (4 strains) and not typeable (12 strains), severe illness resembling Crohn’s disease and affected only
Serotypes 03 or 09  were present in 90% of the culture-pos- adults. Our patients had the more chronic form, whereas
itive patients younger than 15 years but in only 64% of others (17, 18) found only terminal ileitis associated with
patients older than 15 years. At least 2 patients excreted Y. acute pseudoappendicular syndromes. Most of the patients
enterocolitica (both 03) for more than 2 months. None of with chronic forms had negative fecal cultures. After the
the patients with colitis had 03  or 0 9  strains. acute phase organisms migrate to the GALT (Gut Associ-
From 1982 until 1986 90 patients were included. After ated Lymphoid Tissue) and into the mesenteric lymph
introduction of immunoblotting and antigen detection 171 nodes, which we can confirm by antigen detection in biopsy
patients were recognized. Blood or biopsy specimens avail- specimens, and are not excreted anymore. Circulating ag-
able from patients with yersiniosis diagnosed before 1986 glutinins are known to disappear after the acute phase, and
were also tested retrospectively with the new techniques. the agglutinin test will then become negative (2). For these
In 50 of the 54 culture-negative patients both agglutina- patients the new tests including demonstration of antiYops 
tion and immunoblotting were performed. Only 17 of 50 were essential in establishing the correct diagnosis. One
may speculate that a number of patients diagnosed as 
having idiopathic ileitis may in fact suffer from chronic Y.
enterocolitica infection.
This may also be the case for a number of patients with 
‘idiopathic’ colitis, We observed two forms: a very severe, 
acute fulminant form (/? = 10), which was fatal in 3 patients
patients with positive immunoblotting were also agglutinin 
positive {p <  0.0001).
By antigen detection, Yersinia bacilli (5 or more per high 
power microscopic field) were found in or between the 
epithelial cells, in the infiltrates and lymphoid tissue. A 
total of 40 biopsy specimens were cultured but only 1 was
DISCUSSION
positive. A second biopsy after 6 months was taken from 8 and a more chronic ‘ulcerative colitis’ form in 4 patients, 
patients. They were found positive in 5 patients. Like others we found colitis restricted to adults (19).
Yersinia-associated complications were found especially 
in adult patients with chronic rather than acute forms. Both 
female and male were equally affected by all forms of 
complications, except for erythema nodosum which was 
found predominantly in women (9 females vs 2 males, 
p = 0.06). Persistence of infection may be responsible for or 
involved in these complications (3). Age may be an impor­
tant determinant for the seriousness of the course of dis- 
although we observed some families with more than 1 case. ease, as we found that yersiniosis at an older age often had 
The incidence of uncomplicated enteritis was highest in a complicated course. So far, no satisfactory explanation 
young children. It is probable that the incidence in this age for this phenomenon has been found.
Yersiniosis is a rather common disease in The Netherlands. 
The incidence seems rather high compared with most Eu­
ropean countries (11). However, in Belgium an isolation 
rate of 5.9% has been reported previously (12). Epidemiol­
ogy and transmission were not investigated in this study,
group is even higher, as it is often a mild, self-limiting The strains cultured in this study belonged to the
disease at that age. In this study bloody stools were an serotypes commonly in Europe (5, 9). We also isolated 20
exception in young children. Bloody stools in children are strains which only reacted with antiserum against serotype
found in variable percentages (16-29%) (13, 14). Most of 08, a type that generally is not present in Europe. We
our children were seen by general practitioners in an outpa- suggest that this type shows high similarity and therefore
tient setting as we reported earlier (15). cross-reacts with the American 08 strain (5) as was also
The long duration of the diarrhea in 25% of the patients described in other European strains (20). 29 strains did not
with enteritis was remarkable. Reports from Norway also belong to the serotypes 03, 08 or 09. The pathogenic
mention the chronicity of Yersinia enteritis (14). The more potential of such strains is controversial, but several reports
generalized and complicated course of Yersinia enteritis have been published on the relationship between these
was mainly seen in adults (>18 years, 34%) and not in ‘unusual’ serotypes or biogroups and clinical disease, even
children (11%). This observation is in contrast with that with fatal outcome (21-23). We isolated unusual serotypes
reported by others (16) who found complications in up to more often from older patients and espocialJy from patients
7%, but fits well with the observation of Orloff et al. (14) with colitis. Similarly Capriolo et al (21) observed that
who showed joint pain to be a frequent complication (52%) ‘unusuar serotypes were associated with advancing age. We
in adults with enteritis. Abdominal pain is a cardinal have demonstrated previously that 15 20% of young
feature of Yersinia enteric infections, with pseudoappendic- healthy adults in endemic areas have circulating IgG spe-
ular syndrome the most prominent and classic. It was the cific to 1 or 2 Yops (24), reflecting contact with virulent
reason for emergency surgery in 20 patients and like others 
(17) we experienced that surgery was not efficacious in all 
patients.
The tendency to chronicity was also a cardinal feature, 
especially in patients with ileitis, which presented as a ity of unusual serotypes.
Yersinia strains in childhood. These antibodies may protect 
against reinfection by common types al an older age. This 
could explain the shift to ‘unusuar serotypes at an older 
age. Further studies are needed to elucidate the pathogenic-
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Antimicrobial treatment does not seem to influence the 
course and duration of illness in uncomplicated enteritis 
but an effect on shedding of the organism has been de­
scribed (14). However the effect of antibiotics on compli­
cated yersiniosis is still not clear. The frequency and 
seriousness of these complications require controlled trials 
with various antimicrobials.
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